Beck, Alexander https://orcid.org/0000-0001-8641-7832
Gabler-Pamer, Lisa
Alencastro Veiga Cruzeiro, Gustavo
Lambo, Sander
Englinger, Bernhard
Shaw, McKenzie L.
Hack, Olivia A.
Liu, Ilon https://orcid.org/0000-0002-6186-3630
Haase, Rebecca D.
de Biagi, Carlos A. O. Jr https://orcid.org/0000-0003-0700-3135
Baumgartner, Alicia
Nascimento Silva, Andrezza Do
Klenner, Marbod
Freidel, Pia S.
Herms, Jochen https://orcid.org/0000-0002-6201-1042
von Baumgarten, Louisa https://orcid.org/0000-0002-6634-0927
Tonn, Joerg C. https://orcid.org/0009-0004-1756-423X
Thon, Niklas
Bruckner, Katharina https://orcid.org/0000-0002-6633-4009
Madlener, Sibylle https://orcid.org/0000-0001-7099-9997
Mayr, Lisa https://orcid.org/0000-0002-6841-0749
Senfter, Daniel
Peyrl, Andreas https://orcid.org/0000-0002-5736-8231
Slavc, Irene https://orcid.org/0000-0002-9419-6790
Lötsch, Daniela
Dorfer, Christian https://orcid.org/0000-0002-1843-7732
Geyregger, Rene
Amberg, Nicole https://orcid.org/0000-0002-3183-8207
Haberler, Christine
Mack, Norman
Schwalm, Benjamin
Pfister, Stefan M. https://orcid.org/0000-0002-5447-5322
Korshunov, Andrey
Baird, Lissa C. https://orcid.org/0000-0001-7996-1020
Yang, Edward
Chi, Susan N. https://orcid.org/0000-0001-7753-878X
Alexandrescu, Sanda
Gojo, Johannes
Kool, Marcel https://orcid.org/0000-0002-6557-5468
Hovestadt, Volker https://orcid.org/0000-0002-3480-6649
Filbin, Mariella G. https://orcid.org/0000-0002-2613-8126
Article History
Received: 24 August 2024
Accepted: 1 April 2025
First Online: 26 May 2025
Competing interests
: M.G.F. is a consultant for Twentyeight-Seven Therapeutics and Blueprint Medicines. J.C.T. serves as a consultant for Advanced Accelerator Applications-Novartis. The other authors declare no competing interests.